Four webinar series — Heme Horizons, Pallitalks, OncoConnect and GU Webinars — alongside journal clubs, awareness days and community events.
Our webinar series each focus on a different part of cancer care, running through the year as sessions are scheduled. Alongside them we support journal clubs, awareness days and community events. Filter by series, or browse everything under All.
CAR-T Cell Therapy: From Origins to the Future
The story of CAR-T cell therapy from its origins to its future role, and what it means for the place of chemotherapy in haematological malignancies.
An OncoConnect session on neuroendocrine tumours, covering the current treatment landscape and the role of PRRT in management.
Advances in Lymphoma and Adult ALL
CAR-T cell therapy across aggressive and indolent B-cell lymphomas and its expanding role in adult acute lymphoblastic leukaemia.
All You Need to Know
An overview of how the treatment landscape in multiple myeloma is shifting, and what clinicians need to know to apply it in practice.
Under the theme Year of Community
EORA, in collaboration with the UAE Offroaders, invited the community to join the annual Pink Drive for Breast Cancer Awareness under the theme Year of Community.
An EORA-endorsed journal club reviewing preoperative breast MRI in early-stage breast cancer and the PACE-A trial in localised prostate cancer.
From guidelines to clinical practice: global standards, anti-GD2 and chemoimmunotherapy approaches, and local experience in managing high-risk neuroblastoma.
Optimizing the Treatment Journey
How BCMA-directed therapies are sequenced across the myeloma treatment journey, with practical guidance on patient selection and timing.
Emergency Toxicity Pathways and AKI Protection in HDMTX
A multidisciplinary look at recognising delayed methotrexate elimination early, running emergency toxicity pathways, and protecting renal function during high-dose methotrexate.
and Emergency Toxicity Pathways and AKI Protection in HDMTX Meeting
The Abu Dhabi edition of the DME meeting, covering emergency toxicity pathways and renal protection in high-dose methotrexate care.
Latest Evidence and Case-Based Insights
Current evidence in relapsed and refractory myeloma, worked through case discussion with the speaker faculty.
Evolving treatment paradigms in metastatic urothelial carcinoma alongside a comprehensive review of metastatic hormone-sensitive prostate cancer.
Optimizing the Treatment Journey
A focused hour on BCMA sequencing strategy in multiple myeloma and how it shapes the wider treatment journey.
Latest Updates & Hard-to-Treat Cases
The latest CLL evidence alongside three hard-to-treat case presentations and open discussion with the faculty.
International and UAE perspectives on translating neuroblastoma innovation into survival, with a case presentation and discussion.
From Diagnosis to Management
Diagnosis, disease staging and symptom assessment in myelofibrosis, followed by the current treatment landscape and day-to-day management.
PARP inhibitor and novel hormonal agent combinations in mCRPC, from PROpel efficacy and safety data through to real-world evidence and Gulf clinical practice.
A short Pallitalks session on the emerging role of dexmedetomidine in palliative care, followed by open discussion.
EORA supports World Radiotherapy Awareness Day, marked each year on 7 September to raise understanding of radiotherapy and its role in cancer care.
Session dates and faculty for the webinar series are confirmed on a rolling basis. Join the mailing list, or write to us to propose a topic.
Contact the secretariat
